19 June 2013
Keywords: b-ms, abatacept, shows, promise, rheumatoid, arthritis, phase
Article | 25 October 2004
New data from two Phase III trials presented at the American College of Rheumatology annual meeting in San Antonio, Texas, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
25 October 2004
18 June 2013
© 2013 thepharmaletter.com